Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Mohamed El HafiFaculty of Medicine and Pharmacy, Mohammed First University, Oujda 60000, Morocco.ORCID 0000-0002-5243-8886
El Hassane AnouarDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0001-9240-7163
Sanae LahmidiLaboratory of Heterocyclic Organic Chemistry, Department of Chemistry, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.ORCID 0000-0002-8846-1148
Mohammed BoulhaouaLaboratory of Heterocyclic Organic Chemistry, Department of Chemistry, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.ORCID 0000-0002-0708-8653
Mohammed LoubidiDepartment of Chemistry, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech 40000, Morocco.ORCID 0000-0001-5382-8088
Ashwag S AlanaziDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-1042-8126
Insaf FilaliDepartment of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-9524-175X
Mohamed HefnawyDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Lhoussaine El GhayatiLaboratory of Heterocyclic Organic Chemistry, Department of Chemistry, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.
Joel T MagueDepartment of Chemistry, Tulane University, New Orleans, LA 70118, USA.ORCID 0000-0003-3488-1945
El Mokhtar EssassiLaboratory of Heterocyclic Organic Chemistry, Department of Chemistry, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10106, Morocco.
Funding
The authors also extend their appreciation to the Researchers Supporting Project number (RSPD2024R754), King Saud University, Riyadh 11451, Saudi Arabia for supporting this work RSPD2024R754The authors extend their appreciation to Princess Nourah bint Abdulrahman University re-searcher supporting project number (PNURSP2024R342), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia for supporting this work PNURSP2024R342This study is supported via funding from Prince Sattam bin Abdulaziz University project number (PSAU/2023/R/1445) (PSAU/2023/R/1445
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis of New Pyrazolo[3,4- · full record | OpenQuestion